Tony Michael Argenbright

Array ( [id] => 6730687 [patent_doc_number] => 20030186877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Helical peptidomimetics' [patent_app_type] => new [patent_app_number] => 10/367599 [patent_app_country] => US [patent_app_date] => 2003-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10317 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186877.pdf [firstpage_image] =>[orig_patent_app_number] => 10367599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6769498 [patent_doc_number] => 20030215438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Enzyme treatment of foodstuffs for celiac sprue' [patent_app_type] => new [patent_app_number] => 10/367405 [patent_app_country] => US [patent_app_date] => 2003-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 22254 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20030215438.pdf [firstpage_image] =>[orig_patent_app_number] => 10367405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 658788 [patent_doc_number] => 07105637 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-12 [patent_title] => 'Dehydro-estriol (8-DHE3) and dehydro-pregnanetriol (7-DHPT), methods of their synthesis' [patent_app_type] => utility [patent_app_number] => 10/367096 [patent_app_country] => US [patent_app_date] => 2003-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7436 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/105/07105637.pdf [firstpage_image] =>[orig_patent_app_number] => 10367096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6822309 [patent_doc_number] => 20030220470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Methods for the purification of stable radioiodine conjugates' [patent_app_type] => new [patent_app_number] => 10/359276 [patent_app_country] => US [patent_app_date] => 2003-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5461 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220470.pdf [firstpage_image] =>[orig_patent_app_number] => 10359276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5000328 [patent_doc_number] => 20070042962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Peptide dependent upregulation of telomerase expression' [patent_app_type] => utility [patent_app_number] => 10/511530 [patent_app_country] => US [patent_app_date] => 2003-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20044 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20070042962.pdf [firstpage_image] =>[orig_patent_app_number] => 10511530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7448627 [patent_doc_number] => 20040009911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Hepsin substrates and prodrugs' [patent_app_type] => new [patent_app_number] => 10/356656 [patent_app_country] => US [patent_app_date] => 2003-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20893 [patent_no_of_claims] => 92 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20040009911.pdf [firstpage_image] =>[orig_patent_app_number] => 10356656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6702108 [patent_doc_number] => 20030224988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Methods of modulating beta cell function' [patent_app_type] => new [patent_app_number] => 10/355645 [patent_app_country] => US [patent_app_date] => 2003-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22078 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20030224988.pdf [firstpage_image] =>[orig_patent_app_number] => 10355645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7310500 [patent_doc_number] => 20040142903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Bioavailable fenofibrate compositions, methods for treating hyperlipidemia and hypercholesterolemia and processes for the preparation of such compositions' [patent_app_type] => new [patent_app_number] => 10/345882 [patent_app_country] => US [patent_app_date] => 2003-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3903 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142903.pdf [firstpage_image] =>[orig_patent_app_number] => 10345882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1068791 [patent_doc_number] => 06844317 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-18 [patent_title] => 'Methods for oxygen transport comprising a high oxygen affinity modified hemoglobin' [patent_app_type] => utility [patent_app_number] => 10/340141 [patent_app_country] => US [patent_app_date] => 2003-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12500 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/844/06844317.pdf [firstpage_image] =>[orig_patent_app_number] => 10340141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6664524 [patent_doc_number] => 20030203850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'Transdifferentiation of pancreatic acinar cells' [patent_app_type] => new [patent_app_number] => 10/338028 [patent_app_country] => US [patent_app_date] => 2003-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2853 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20030203850.pdf [firstpage_image] =>[orig_patent_app_number] => 10338028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6852003 [patent_doc_number] => 20030144206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Combined use of a GLP-1 compound and modulator of diabetic late complications' [patent_app_type] => new [patent_app_number] => 10/328282 [patent_app_country] => US [patent_app_date] => 2002-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6503 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144206.pdf [firstpage_image] =>[orig_patent_app_number] => 10328282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7473729 [patent_doc_number] => 20040121949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Composition comprising partly-hydrolysed fish gelatin and a method for treatment of a patient suffering from arthrosis, osteoporosis and other diseases' [patent_app_type] => new [patent_app_number] => 10/324857 [patent_app_country] => US [patent_app_date] => 2002-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3306 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20040121949.pdf [firstpage_image] =>[orig_patent_app_number] => 10324857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6852045 [patent_doc_number] => 20030144248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Surfactant prevention of lung complications from cancer chemotherapy' [patent_app_type] => new [patent_app_number] => 10/317787 [patent_app_country] => US [patent_app_date] => 2002-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7180 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144248.pdf [firstpage_image] =>[orig_patent_app_number] => 10317787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7397114 [patent_doc_number] => 20040038872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => ' Inhibitors of hepatitis C virus' [patent_app_type] => new [patent_app_number] => 10/317451 [patent_app_country] => US [patent_app_date] => 2002-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48064 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038872.pdf [firstpage_image] =>[orig_patent_app_number] => 10317451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6668287 [patent_doc_number] => 20030113270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Vasoactive intestinal peptides for glaucomatous retinopathy' [patent_app_type] => new [patent_app_number] => 10/313571 [patent_app_country] => US [patent_app_date] => 2002-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1776 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20030113270.pdf [firstpage_image] =>[orig_patent_app_number] => 10313571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5637484 [patent_doc_number] => 20060068457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Substrates for tafi (a)' [patent_app_type] => utility [patent_app_number] => 10/530165 [patent_app_country] => US [patent_app_date] => 2002-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2383 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20060068457.pdf [firstpage_image] =>[orig_patent_app_number] => 10530165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5662319 [patent_doc_number] => 20060252915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Antimicrobial bolisin peptides' [patent_app_type] => utility [patent_app_number] => 10/497909 [patent_app_country] => US [patent_app_date] => 2002-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4228 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20060252915.pdf [firstpage_image] =>[orig_patent_app_number] => 10497909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6706786 [patent_doc_number] => 20030153520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Control of membrane traffic' [patent_app_type] => new [patent_app_number] => 10/203742 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18294 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20030153520.pdf [firstpage_image] =>[orig_patent_app_number] => 10203742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6725500 [patent_doc_number] => 20030207812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Cd45 inhibitors' [patent_app_type] => new [patent_app_number] => 10/168758 [patent_app_country] => US [patent_app_date] => 2002-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16167 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207812.pdf [firstpage_image] =>[orig_patent_app_number] => 10168758 [rel_patent_id] =>[rel_patent_doc_number] =>)